Home / Mesothelioma.net / Efficacy of Immunotherapy May Be Offset by Adverse Events in Mesothelioma Patients 

Efficacy of Immunotherapy May Be Offset by Adverse Events in Mesothelioma Patients 

A just-released study conducted in the Netherlands provides a mixed assessment of the use of nivolumab-ipilimumab immunotherapy in patients with...

from Mesothelioma.net https://ift.tt/EQgnuBP
via IFTTT
Efficacy of Immunotherapy May Be Offset by Adverse Events in Mesothelioma Patients  Efficacy of Immunotherapy May Be Offset by Adverse Events in Mesothelioma Patients  Reviewed by Unknown on December 15, 2023 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.